PCRS is deeply concerned about the takeover of Vectura, a pharmaceutical company producing medicines for the treatment of respiratory disease, by Philip Morris International, a company whose tobacco products continue to cause addiction, suffering and death around the world.
Top Tips for Facilitating Online Meetings
In association with Sandoz, we are delighted to be hosting a new webinar series on asthma care
PCRS is currently seeking two new Trustees. All interested applicants are invited to apply. In particular, we are looking for Trustees with background or experience in law (charity or commercial) and/or commercial/corporate partnerships and/or the pharmaceutical industry.
In association with Sandoz, we are delighted to be hosting this webinar series on asthma care
In this infographic PCRS distills key 2021 guidance from NICE on the identification of COVID-19, assessment, community management and advice to provide patients on managing their symptoms.
As we prepare to enter another wave of SARS-CoV-2 infections whilst we continue to deal with the backlog of patients who have had their treatments and assessments delayed by the pandemic, what is challenging the NHS even more are the long-term effects following SARS-CoV-2 infection – so call
Tuesday 19th October 2021, 18:00 - 19:00
Tuesday 16th November 2021, 18:00 - 19:00
Alongside BTS, ERS, ATS and many other healthcare groups PCRS has submitted a letter to Vectura Board Members urging them to reject the acquisition offer by tobacco products manufacturer Philip Morris I
Wednesday 15th September 2021, 18:00 - 19:00
In association with Sandoz, we are delighted to be hosting a new webinar series on asthma care
PCRS is delighted to announce that Simpson Millar has joined forces with PCRS to support our fantastic network of local respiratory groups – the PCRS Peer Support Network.
In association with Sandoz, we are delighted to be hosting this webinar series on asthma care
This pragmatic guide has been developed based on the work of the PCRS Greener Healthcare Working Group.